• Save
Leukemia Therapeutics Market to 2018 Market Research Report

Like this? Share it with your network

Share

Leukemia Therapeutics Market to 2018 Market Research Report

  • 814 views
Uploaded on

(Price :$3500) The report provides an in-depth analysis of the major leukemia indications including acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myelocytic leukemia......

(Price :$3500) The report provides an in-depth analysis of the major leukemia indications including acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myelocytic leukemia (AML) and chronic myelocytic leukemia (CML). The report examines the global leukemia diseases treatment usage patterns. In addition, the geographical distribution of leukemia therapeutics and markets across the US, the top five countries of Europe and in Japan are provided in the report.

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
814
On Slideshare
814
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Category : Healthcare , Therapeuticwww.MarketResearchReports.com
  • 2. Introduction to Report Launch Date: 1st November, 2012 Number of Pages: 145 Geography Coverage: Global Available Format: PDF Price For Single User License: USD 3,500 Price For Global User License: USD 7,000 Price For Global User License: USD 10,500 Delivery Time: Within 24 Hours (During Working Days) www.MarketResearchReports.com
  • 3. Report Facts:In 2011, the leukemia therapeutics market for fourmajor leukemia indications was estimated at $4.0 billion indicating a compound annual growth rate (CAGR) of21.0% since 2004Market to grow at a CAGR of 9.5% between 2011 and2018 to reach to $7.6 billion by 2018 The US was the leading market with an estimatedsales value of $1.8 billion in 2011 and an approximateshare of 44.3%The US market is expected to grow at a CAGR of 10.0%between 2011 and 2018 to record sales value of $3.5billion in 2018 www.MarketResearchReports.com
  • 4. Report Facts Continued:The top five countries of Europe together contributedto sales worth $1.5 billion in 2011 approximate share of37.9%The top five countries of Europe are expected to recordsales worth $3.1 billion by the year 2018, at a CAGR of10.3%.Japan, in 2011, contributed $720m to the global marketincreasing at a CAGR of 20.8% from 2004. It accountsfor an approximate share of 17.8%. Growing at a CAGR of 6.1% between 2011 and 2018,the market is expected to record sales worth $1.1 billionby 2018. www.MarketResearchReports.com
  • 5. Scope of the Report :Data and analysis on the leukemia therapeutics marketin the leading geographies of the world – the US, Japan,the UK, Germany, France, Italy and SpainAnnualized market data for the leukemia therapeuticsmarket from 2004 to 2011, with forecasts to 2018Market data on the geographical landscape andtherapeutic landscape.Key drivers and restraints that have had a significantimpact on the marketKey M&A activities and licensing agreements that tookplace in 2009 and 2011 in the leukemia therapeuticsmarket. www.MarketResearchReports.com
  • 6. Reason to Buy:Data and analysis on the leukemia therapeutics marketin the leading geographies of Align your productportfolio to the markets with high growth potential.Build effective strategies to launch their pipelineproducts by identifying potential geographies.Develop key strategic initiatives by studying the keystrategies of top competitors.Develop market-entry and market expansion strategiesby identifying the geographic markets poised for stronggrowth.Reinforce R&D pipelines by identifying new targetmechanisms which can produce first-in-class moleculeswhich are safer and more efficacious. www.MarketResearchReports.com
  • 7. Report Coverage:Leukemia Market to 2018 - IntroductionLeukemia Market to 2018 - Market OverviewLeukemia Market to 2018 - Geographical LandscapeLeukemia Market to 2018 - Therapeutic LandscapeLeukemia Market to 2018 - Pipeline AnalysisLeukemia Market to 2018 - Competitive LandscapeLeukemia Market to 2018 - Strategic Consolidations www.MarketResearchReports.com
  • 8. Companies Covered:1. Novartis AG2. GlaxoSmithKline plc (GSK)3. Genzyme Corporation4. Bristol-Myers Squibb Company (BMS)5. Eisai Co., Ltd. www.MarketResearchReports.com
  • 9. How To Buy This Report?Visit following URL to see Table of Content andpurchase this publication:http://www.marketresearchreports.com/gbi-research/leukemia-therapeutics-market-2018-strong-late-stage-pipeline-sustain-branded-drugs About Market Research ReportsMarket Research Reports provides a customized setof reports from reputed Publishers, built on theintelligence available within organizations andleverages on our motto of “Intelligence Redefined”. Contact : Amitava Sen Email : info@marketresearchreports.com Phone: +91-8762746600 www.MarketResearchReports.com